Approvals/TGA/DBL OXALIPLATIN oxaliplatin concentrate for infusion vial 50mg/10mL

Approved

STANDARD

DBL OXALIPLATIN oxaliplatin concentrate for infusion vial 50mg/10mL

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7f760bdc7a356444
Product Name: DBL OXALIPLATIN oxaliplatin concentrate for infusion vial 50mg/10mL
Artg Id: 131754
Artg Name: DBL OXALIPLATIN oxaliplatin concentrate for infusion 50mg/10mL vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2009-02-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/87d6453eb555acb52d7d100d83a4288f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/32565385caac62230aae721616941de5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

7f760bdc7a356444

Type

Standard